Mianserin Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Serotonin receptor antagonist. Antidepressant
Weltgesundheitsorganisation (WHO)
Mianserin, a serotonin antagonist with antidepressant and
antihistaminic activity, was introduced in 1975 for the treatment of depressive
illness. Its use has since been associated with cases of severe blood dyscrasias,
particularly in elderly patients, including agranulocytosis, leucopenia and
granulocytopenia. Several drug regulatory authorities have reacted by stipulating
that blood counts should be monitored regularly during the first few months of
treatment and that administration should be discontinued immediately should any
signs possibly indicative of dyscrasia develop.
Mianserin Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
